Dr. Scott Gottlieb Visits Eagle’s New Facility
Eagle President and CEO Dr. Ross Caputo took the opportunity to share our mission of ensuring the safety and quality of compounded preparations through science-based solutions. Dr. Gottlieb was also given an overview of Eagle’s aim to impact the compounding industry by promoting practices that both meet and exceed regulatory expectations.
Gottlieb served as the 23rd Commissioner of the FDA from May 2017 to April 2019. He is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs, and before that, as a senior advisor to the FDA Commissioner (1).
- How to Keep Schools, Businesses, and Homes Clean During COVID-19 - June 2, 2020
- Shhh! Study Shows Talking May Spread COVID-19 - May 29, 2020
- FDA Updates Guidance On Adverse Reporting During a Pandemic - May 21, 2020